(Q37914061)

25 August 2017

1 reference

title

A rationale for mTOR inhibitors as chemoprevention agents in Peutz-Jeghers syndrome (English)

1 reference

25 August 2017

Scott K Kuwada

1

1 reference

PubMed ID

21826537

25 August 2017

Randall Burt

series ordinal

2

1 reference

25 August 2017

1 September 2011

1 reference

25 August 2017

1 reference

25 August 2017

10

1 reference

25 August 2017

3

1 reference

25 August 2017

469-472

1 reference

https://scigraph.springernature.com/pub.10.1007/s10689-011-9471-9

25 August 2017

0 references

cites work

Neoplastic transformation arising in Peutz-Jeghers polyposis.

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9471-9

Peutz-Jeghers polyposis associated with carcinoma of the digestive organs. Report of three cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9471-9

Frequency and spectrum of cancers in the Peutz-Jeghers syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9471-9

High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9471-9

The prevalence of PIK3CA mutations in gastric and colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9471-9

Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9471-9

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9471-9

Suppression of Peutz-Jeghers polyposis by targeting mammalian target of rapamycin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9471-9

Chemopreventive efficacy of rapamycin on Peutz-Jeghers syndrome in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9471-9

mTOR and HIF-1alpha-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9471-9

Oral rapamycin reduces tumour burden and vascularization in Lkb1(+/-) mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9471-9

Rapamycin causes regression of astrocytomas in tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9471-9

Cyclooxygenase 2 expression and molecular alterations in Peutz-Jeghers hamartomas and carcinomas

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21826537

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Small-intestinal Peutz-Jeghers polyps resected by endoscopic polypectomy with double-balloon enteroscopy and removal confirmed by ultrasonography

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21826537

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Radical Endoscopic Polypectomy Combined With Double-balloon Enteroscopy and Colonoscopy for Peutz-Jeghers Syndrome

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21826537

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10689-011-9471-9

1 reference

25 August 2017

1 reference

PubMed ID

21826537